Carbapenemase-producing organisms in solid organ transplantation

Area of Science:

• Infectious Diseases
• Transplant Medicine
• Public Health

Background:

• Carbapenem-resistant Enterobacteriaceae (CRE) represent a critical global healthcare challenge.
• Transplant recipients are disproportionately affected by CRE infections, with up to 10% developing these infections.
• Existing literature is reviewed, emphasizing transplant-specific implications of CRE.

Purpose of the Study:

• To review current literature on Carbapenem-resistant Enterobacteriaceae (CRE).
• To focus on the specific implications of CRE infections in transplant recipients.
• To highlight the elevated risk and varied manifestations of CRE in this vulnerable population.

Main Methods:

• Retrospective case study analysis.
• Literature review focusing on transplant-specific data.
• Synthesis of current knowledge on CRE in transplant recipients.

Main Results:

• Transplant recipients face inherent risks leading to increased CRE carriage and infection.
• CRE infection manifestations vary based on the type of transplant.
• Optimal treatment strategies for CRE in transplant recipients remain undefined.

Conclusions:

• Reducing community CRE burden through antibiotic stewardship and infection control benefits transplant populations.
• An integrated strategy for risk stratification and treatment is proposed for CRE management in solid-organ transplant recipients.
• A multi-level healthcare approach is essential to combat the CRE health crisis.